AXNX (Axonics) Net Profit

Corporate emblem and logo of axonics.com (AXNX)

The stability of Axonics, Inc. (AXNX) is supported by strict control over component suppliers, which is reflected in the company's real profit dynamics. The operational base relies on the training of neuromodulation physicians and expansion into the bladder implant niche. The current value of -0.00 represents the latest metric reading, capturing business efficiency and the market consensus regarding the issuer's revenues.

AXNX: Axonics, Inc. Net Profit 07/04/2022 - 10/29/2026

Financial and market metric breakdowns for Axonics (AXNX)

- current quotes and average value forecast:
Market Chart Axonics, Inc|AXNX - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Axonics, Inc|AXNX - Total Company Value
- book capitalization data:
Net Assets per Single Share Axonics|AXNX - Book Capitalization|Market Capitalization to Book Value axonics.com|AXNX - Cumulative Company Assets
- debt and liquidity details:
Aggregate Debt to Equity Axonics, Inc.|AXNX - Long-Term Debt to Capital|Current Liabilities to Capital Axonics Inc.|AXNX - Company Aggregate Debts|Debt to Book Value Ratio Axonics, Inc|AXNX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Axonics|Quick Liquidity Indicator axonics.com
- earnings and valuation multiples information:
AXNX - Net Profit
Fundamental valuation:Axonics, Inc
Product sample of Axonics, Inc.

This indicator reflects the net financial result, allowing for an assessment of the business's ability to generate bottom-line income after deducting all expenses and tax liabilities. An analysis of Axonics, Inc. (AXNX) net balance helps determine investment stability, where an upward trend confirms the effective scaling of r-SNM neuromodulation system sales and their competitiveness in treating bladder dysfunction.

Key competitors

BSX - Net Financial Result|EW (Edwards Lifesciences) - Net Profit|Net Profit resmed.com|Company Net Income Insulet (PODD)|Company Net Income ZBH (Zimmer Biomet Holdings)|Net Profit COO (CooperVision)|Net Financial Result Align Corp (ALGN)|GMED: Net Income|Profit After Tax TMDX|ATEC: Net Profit|Company Net Income CryoLife (AORT)|ENOV (DJO Global) - Net Profit|Company Profit IART (Integra LifeSciences Inc.)|Net Income ESTA (Establishment Labs)|BBNX (betabionics.com) - Final Profit|Company Net Income IRADIMED IRMD|EMBC - Net Income|Tandem Diabetes - Net Profit|Company Net Income Axogen Surgical|SIBN: Net Profit|Company Profit OFIX|BVS (Bioventus) - Net Profit|OrthoPediatrics Inc. (KIDS) - Net Financial Result|Net Profit TMCI|Net Income Strata Medical SRTA|Net Profit CARL (Carlsmed Inc)|Net Profit rxsight.com RXST|CLPT - Company Net Income|STXS: Company Net Income|STIM (NeuroStar) - Net Income|Sight Sciences Inc - Final Profit|OBIO (Orchestra BioMed) - Net Profit|Company Net Income Anika ANIK|Company Net Income InspireMD (NSPR)|zhjmedical.com (ZJYL) - Annual Net Income|Vivani Medical - Net Income|Net Profit Xtant Medical Holdings, Inc. XTNT|NeuroOne Medical Technologies - Net Profit|Net Financial Result Modular Medical MODD|Myomo (MYO) - Company Net Income|Profit After Tax COCH (Envoy Medical Inc.)|Company Net Income Vivos Therapeutics, Inc|Net Income enVVeno Corp (NVNO)|Net Profit SINT|TNON - Company Net Income|Company Net Income Lifeward LFWD|AMIX: Company Profit|IVF: Net Income|Bone Biologics Inc - Profit After Payment of Taxes|BIOL: Net Profit|Dynatronics (DYNT) - Net Profit|Net Income FNA|Company Profit INVO (INVO Bio)